NASDAQ:TRIB Trinity Biotech Q2 2025 Earnings Report $6.32 -0.11 (-1.71%) Closing price 10/1/2026 03:47 PM EasternExtended Trading$6.32 0.00 (-0.02%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Trinity Biotech EPS ResultsActual EPS-$9.60Consensus EPS -$44.40Beat/MissBeat by +$34.80One Year Ago EPSN/ATrinity Biotech Revenue ResultsActual Revenue$9.20 millionExpected Revenue$10.50 millionBeat/MissMissed by -$1.30 millionYoY Revenue GrowthN/ATrinity Biotech Announcement DetailsQuarterQ2 2025Date1/2/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsTrinity Biotech's Q2 2026 earnings is estimated for Thursday, December 10, 2026, based on past reporting schedulesConference Call ResourcesSlide DeckEarnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Earnings Documents Trinity Biotech Earnings HeadlinesCritical Comparison: Trinity Biotech (NASDAQ:TRIB) & Nuwellis (NASDAQ:NUWE)September 28, 2026 | americanbankingnews.comTrinity Biotech Signs Contract With Red Team Investments For AI Data Center Cooling SolutionsSeptember 9, 2026 | rttnews.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.October 2 at 1:00 AM | Altimetry (Ad)Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center InfrastructureSeptember 9, 2026 | finance.yahoo.comTrinity Biotech's Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center InfrastructureSeptember 9, 2026 | globenewswire.comTrinity Issues Updates On Diagnostics Launch; Plans To Regain Nasdaq Compliance By Feb '27August 31, 2026 | rttnews.comSee More Trinity Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Trinity Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Trinity Biotech and other key companies, straight to your email. Email Address About Trinity BiotechTrinity Biotech (NASDAQ:TRIB) is a biotechnology and medical diagnostics company headquartered in Ireland. The company develops, manufactures and markets diagnostic products used by clinical laboratories, healthcare providers and other testing facilities. Its offerings are designed to support the detection and management of infectious diseases, autoimmune conditions and other medical disorders. Trinity Biotech’s portfolio has historically included point-of-care and laboratory-based tests for conditions such as HIV, hepatitis, syphilis and autoimmune diseases. The company has also provided clinical laboratory services and diagnostic technologies, serving healthcare markets in North America, Europe and other international regions through direct operations, distributors and strategic relationships. Founded in 1992, Trinity Biotech has expanded through internal development and acquisitions of diagnostic businesses and technologies. Its products are used in a range of settings, including hospitals, reference laboratories, physician offices, public-health programs and resource-limited environments where rapid testing can be important.View Trinity Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Micron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket ReachJabil’s Double-Beat and Raise Is a Signal That This Rally Will ContinueMicrosoft's AI Spending Didn't Change—Wall Street's View of It DidL3Harris’ $6 Billion THAAD Win Comes at a Crucial Moment for the Stock Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
